
Todd D. Rozen, MD
Advertisement
Articles by Todd D. Rozen, MD

Advertisement
Latest Updated Articles
Management of Migraine: Opportunity or Bottomless Pit?October 1st 1998
Advertisement
Advertisement
Trending on AJMC
1
5 August FDA Approvals Marked by Novelty, Pushback
2
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
3
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
4
Cross-Trial Vitiligo Data: What Payers Can and Can't Compare
5